Researchers develop a new approach to mapping the individual heterogeneity of brain changes in mental disorders

In vivo animal models have brought much to the science behind the drug development industry, but how far behind are organ-on-a-chip models?

Intellegens CEO Ben Pellegrini explains how machine learning is set to change the oligonucleotide manufacturing landscape

It’s official: CRISPR medicines are here as UK authorizes exa-cel.

Experimental insomnia drug shows promise in alleviating opioid withdrawal symptoms and opioid-seeking behavior

After serving as Head of Research Development at Trinity College Dublin, Fiona Killard-Lynch became Director of Research and Innovation at NIBRT

Deepika Khedekar explores the unique environment of space and its implications for clinical research.

Exploring the role of AI in helping bring more medicines to market.

Never underestimate the meticulousness with which authorities operate or the standards that businesses are expected to adhere to.

Voting is now open for the 2024 Company of the Year Awards – vote for the best big pharma, best CDMO, and more!